| Patient Education | | |
|
Erythema is redness of the skin caused by increased blood flow to the capillaries. There are many causes and manifestations of erythema, including photosensitivity, erythema multiforme, and erythema nodusum. Photosensitivity refers to a skin reaction in response to the sun; it tends to occur when something, such as an infection or a medication, increases a person's sensitivity to ultraviolet radiation. Erythema multiforme is characterized by spots, blisters, or other lesions on the skin and usually results from a reaction to medications, infections, or illness. Erythema nodosum is a form of erythema that is accompanied by nodules, small round masses, typically on the arms and legs. |
| What Causes It? |
|
In half of all cases of either erythema multiforme or erythema nodosum, the exact cause is not identified. The following are examples of what may precipitate these skin reactions. Erythema multiforme:
Erythema nodosum:
|
| Who's Most At Risk? |
|
| Signs and Symptoms |
|
Erythema multiforme:
Erythema nodosum:
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), perhaps the most severe forms of erythema multiforme, are characterized by a different set of symptoms. Target lesions on the trunk, hacking cough, fever, and blisters around the mouth, eyes, nostrils, and anal and vaginal areas are the key symptoms of SJS. A person with TEN will have symptoms of SJS that eventually worsen to include peeling and detachment of the skin, pus-like infections, fluid loss, and even death. |
| What to Expect at Your Provider's Office |
|
Healthcare providers will perform a physical exam and may use procedures such as a skin biopsy, throat culture, blood test, or X ray to determine the type of erythema. Not only will these procedures help identify the type of skin condition, they may also reveal any infections or medications that are contributing to the symptoms. |
| Treatment Options |
| Prevention |
|
Treat any underlying diseases and avoid any known triggers (certain medications, for example); it is also important to avoid being outside in the sun when taking certain medications that contribute to photosensitivity. |
| Treatment Plan |
|
Healthcare providers will treat any underlying diseases, eliminate drugs that may contribute to symptoms, and take steps to control current symptoms. While mild cases may not require treatment, bed rest and medication may be necessary for more severe cases. |
| Drug Therapies |
|
Healthcare providers may prescribe various medications in the appropriate clinical setting, including:
|
| Complementary and Alternative Therapies |
|
In order to heal any type of erythema, the underlying cause of the skin condition must be treated. Certain complementary and alternative therapies, though, help to:
|
| Nutrition |
|
Antioxidants found in some dietary supplements and topical preparations such as gels, ointments, or lotions may protect against skin damage caused by ultraviolet (UV) sun rays when used prior to exposure. Antioxidants are molecules that scavenge free radicals (highly active molecules that can injure cells and contribute to disease, including skin damage). The following substances with antioxidant activity were found in studies to have benefit in protecting the skin in the circumstances described:
|
| Herbs |
Herbs traditionally used to heal damaged skin, promote lymph circulation, and possibly treat the underlying cause of various skin conditions may be helpful. Although these have not been tested scientifically for erythema specifically, some examples include:
It is best and safest to see a trained, experienced herbalist for guidance about the use of herbs to treat erythema. |
| Homeopathy |
|
To date, only animal studies have shown that homeopathic remedies (Apis in particular) may help protect against UV radiation. However, an experienced homeopath would consider each individual case and may recommend treatments to address both the underlying condition and any current symptoms. Homeopathic remedies commonly used for skin conditions include:
|
| Massage |
|
Massage should be avoided in cases of erythema because it may make any inflammation worse. |
| Prognosis/Possible Complications |
|
When treated properly, signs and symptoms of erythema multiforme usually disappear in four to six weeks; symptoms of erythema nodosum, however, may reappear for up to two years. Symptoms of SJS typically disappear in a month, but when the condition is not treated properly it may lead to blindness. Ten percent may die from more severe forms of SJS. Up to 40 percent of those with TEN may die of the condition. If the drug causing either SJS or TEN is identified and discontinued quickly, a person's chance of survival significantly improves. |
| Following Up |
|
Healthcare providers will monitor fluid and electrolyte levels, protein loss, and any organ damage. Persons with erythema multiforme may need treatment in a hospital burn unit if 20% or more of their body is affected. |
| Special Considerations |
|
Erythema raises special issues related to pregnancy. If a pregnant woman develops erythema infectiosum (fifth disease), the virus can infect the fetus and cause fetal anemia, heart failure, hydrops (collection of watery fluid), and even death. Studies have also shown that pregnancy may trigger erythema nodosum. Finally, certain medications must be avoided during pregnancy; your healthcare provider will be able to direct your care appropriately. |
| Supporting Research |
|
Beers MH, Berkow R. The Merck Manual of Diagnosis and Treatment. 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999. Blumenthal M, Goldberg A, Brinckmann J, eds. Herbal Medicine: Expanded Commission E Monographs. Newton, Mass: Integrative Medicine Communications; 2000:230-239, 253-263, 419-423. Dambro MR, ed. Griffith's 5 Minute Clinical Consult. Baltimore, Md: Lippincott Williams & Wilkins; 1999. Dreher F, Denig N, Gabard B, Schwindt DA, Maibach HI. Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatology. 1999;198(1):52-55. Dreher F, Gabard B, Schwindt DA, Maibach HI. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol. 1998;139(2):332-339. Eberlein-König B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol. J Am Acad Dermatol. 1998;38(1):45-48. Fauci AS, Braunwald E, Isselbacher KJ, et al., eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med. 1998;25(9):1006-1012. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol. 2000;136(3):323-327. Garcia-Porrua C, Gonzalez-Gay MA, Vazquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum. 2000;43(3):584-592. Habif TP. Clinical Dermatology. 3rd ed. St. Louis, Mo: Mosby-Year Book; 1996. Halliday GM, Yuen KS, Bestak R, Barnetson RS. Sunscreens and vitamin E provide some protection to the skin immune system from solar-simulated UV radiation. Australas J Dermatol. 1998;39(2):71-75. Katiyar SK, Matsui MS, Elmets CA, Mukhtar H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol. 1999;69(2):148-153. Khanna VJ, Shieh S, Benjamin J, et al. Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc. Arch Dermatol. 2000;136(6):755-757. Lee J, Jiang S, Levine N, Watson RR. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc Soc Exp Biol Med. 2000;223(2):170-174. Lo SK, Yip D, Leslie M, Harper P. 5-flourouracil-induced erythema multiforme. Int J Clin Pract. 1999;53(3):219-221. Mandell GL, Bennett JE, Dolin R, eds. Principles and Practices of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000. Martinez AE, Atherton DJ. High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatr Dermatol. 2000;17(2):87-90. Murray M. Encyclopedia of Nutritional Supplements. Rocklin, Calif: Prima Publishing; 1996:320-335. Rakel RE, ed. Conn's Current Therapy. 51st ed. Philadelphia, Pa: W.B. Saunders; 1999. Sinclair SA, Reynolds NJ. Necrolytic migratory erythema and zinc deficiency. Br J Dermatol. 1997;136(5):783-785. Stahl W, Heinrich U, Jungmann H, Sies H, Tronnier H. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am J Clin Nutr. 2000;71(3):795-798. Stern RS. Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol. 2000;136(3):410-411. Vickers AJ. Independent replication of pre-clinical research in homoeopathy: a systematic review. Forsch Komplementarmed. 1999;6(6):311-320. |
|
Copyright © 2000 Integrative Medicine Communications The publisher does not accept any responsibility for the accuracy of the information or the consequences arising from the application, use, or misuse of any of the information contained herein, including any injury and/or damage to any person or property as a matter of product liability, negligence, or otherwise. No warranty, expressed or implied, is made in regard to the contents of this material. No claims or endorsements are made for any drugs or compounds currently marketed or in investigative use. This material is not intended as a guide to self-medication. The reader is advised to discuss the information provided here with a doctor, pharmacist, nurse, or other authorized healthcare practitioner and to check product information (including package inserts) regarding dosage, precautions, warnings, interactions, and contraindications before administering any drug, herb, or supplement discussed herein. |
| ... Brought to you
by |